Nuvalent, Inc.

Here is data found by MailMentor on Nuvalent, Inc.

Nuvalent, Inc. is a company specializing in creating precisely targeted therapies for patients with cancer. With deep expertise in chemistry and structure-based drug discovery, Nuvalent is dedicated to developing innovative solutions to combat cancer. They recently announced updated preliminary data from their ALKOVE-1 Trial, which supports their commitment to delivering best-in-class therapies. Additionally, Nuvalent Inc. is holding a $300 million stock offering following promising data from their second lead cancer drug. With a focus on #PreciselyTargetedTherapies, Nuvalent is dedicated to improving the lives of cancer patients.

Find contacts at this company

Our AI enabled web scraper helps you prospects at Nuvalent, Inc. and similar companies

Find out how